The Bionic Leg has been named a winner in the 2010 Medical Design Excellence Awards (MDEA) competition at the Medical Design & Manufacturing East 2010 Conference and Exposition, June 8–10, 2010, in New York City.
Accepting the MDEA award on behalf of Tibion was Robert Horst, Chief Technology Officer. Dr. Horst is the principal developer of the Bionic Leg, and is named on the key patents.
The Tibion Bionic Leg is a wearable robotic device that therapists use to help those disabled by stroke and other diseases to recover their ability to walk without canes and walkers, and to reduce risk of falls. Claremont Creek Ventures (Oakland, CA) and Fogarty Research and Development (Portola Valley, CA) were cited by the awards committee for their contribution to the Bionic Leg development.
The MDEA competition is the premier awards program for the medical technology community.
The program is open worldwide to companies and individuals involved in the design, engineering, manufacture, or distribution of finished medical devices or medical packaging. Awards are offered in 10 categories.
In announcing the winners, the MDEA said the awards recognize the achievements of medical device manufacturers, their suppliers, and the many people behind the scenes—engineers, scientists, designers, clinicians and investors —who are “responsible for the groundbreaking innovations that are changing the face of healthcare.”
Tibion is a privately-held company developing innovative equipment that can help individuals recover physical function lost due to disease, trauma or aging. Its first commercialized product, the Tibion Bionic Leg, actively assists therapists with the rehabilitation of individuals who present with lower extremity dysfunction that impairs function, mobility and gait.